Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/molecular-mechanisms-of-dementia/descriptif_3827007
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3827007

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Molecular Mechanisms of Dementia Biomarkers, Neurochemistry, and Therapy

Langue : Anglais

Auteur :

Couverture de l’ouvrage Molecular Mechanisms of Dementia

Considerable progress has been made in neurochemical and therapeutic aspects of dementia research in recent years. Molecular and Therapeutic Aspects of Dementia presents readers with comprehensive and cutting-edge information on the neurochemical mechanisms of various types of dementias. It provides a clearly written and logically organized and comprehensive overview of molecular aspects of risk factors, symptoms, pathogenesis, biomarkers, and therapeutic strategies for various types of dementia. This book is written for the international audience of neurochemists, neuroscientists, neurologists, neuropharmacologists, and clinicians. The hope is that this discussion will not only integrate and consolidate knowledge in this field, but will jumpstart more studies on molecular mechanisms and therapeutic aspects of dementia.

The comprehensive information in this monograph may not only help in early detection of various types of dementia and dementia linked neurological disorders, but also promote discovery of new drugs, which may block or delay the onset of dementia in elderly patients. Understanding the course of dementia is important not only for patients, caregivers, and health professionals, but also for health policy-makers, who have to plan for national resources needed in the management of an increasing number of dementia cases.

1. Neurochemical Aspects of Dementia2. Neurochemical aspects of post-stroke dementia3. Neurochemical Aspects of Alzheimer’s Type of Dementia4. Neurochemical aspects of Lewy body dementia5. Neurochemical aspects of vascular dementia6. Neurochemical aspects of frontotemporal dementia7. Potential treatment strategies for dementia with pharmacological and non-pharmacological interventions8. Potential treatment strategies for the treatment of dementia with Chinese medicinal plants9. Potential treatment strategies of dementia with Ayurvedic medicines10. Summary and perspective for future research on dementia

researchers, physicians, students in neuroscience, neurology, neurochemistry and neuropharmacology

Akhlaq A. Farooqui is a leader in the field of signal transduction processes, lipid mediators, phospholipases, glutamate neurotoxicity, and neurological disorders. He is a research scientist in the Department of Molecular and Cellular Biochemistry at The Ohio State University. He has published cutting edge research on the role of phospholipases A2 in signal transduction processes, generation and identification of lipid mediators during neurodegeneration by lipidomics. He has studied the involvement of glycerophospholipid, sphingolipid-, and cholesterol-derived lipid mediators in kainic acid neurotoxicity, an experimental model of neurodegenerative diseases. Akhlaq A. Farooqui has discovered the stimulation of plasmalogen- selective phospholipase A2 in brains of patients with Alzheimer disease (AD). Stimulation of this enzyme may not only be responsible for the deficiency of plasmalogens in neural membranes of AD patients, but also be related to the loss of synapse in the AD.
  • Provides a comprehensive overview of molecular aspects of risk factors, symptoms, pathogenesis, biomarkers, and therapeutic strategies for various types of dementia
  • Summarizes cutting edge research information on signal transduction processes associated with neurochemistry of dementia
  • Discusses the synthesis, metabolism, and role of lipid mediators in dementia